Search - tctmd.com

Displaying 341 - 360 of 2113

Sort: Relevancy | Date

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

October 14, 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

News Conference News TCT 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

October 14, 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

October 14, 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

October 14, 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

News Conference News TCT 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

October 14, 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

October 09, 2020

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

News Daily News

ESC and EACTS Announce Review of Left Main Revascularization Guidelines

Michael O'Riordan

October 06, 2020

Young Women With AMICS: High Risk, Inadequate Care

News Daily News

Young Women With AMICS: High Risk, Inadequate Care

September 29, 2020

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

September 24, 2020

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

News Daily News

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

September 22, 2020

Hostility After ACS Linked to All-Cause Mortality

News Daily News

Hostility After ACS Linked to All-Cause Mortality

Michael O'Riordan

September 21, 2020

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

News Daily News

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

September 17, 2020

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

PCI Volumes Rise in US and Japan, but for Different Reasons

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

Multivessel PCI Helps Most in STEMI Patients With Severe Nonculprit Lesions

News Daily News

Multivessel PCI Helps Most in STEMI Patients With Severe Nonculprit Lesions

September 11, 2020

PCI of a Last Remaining Patent Vessel Is Rare and Risky, UK Data Confirm

News Daily News

PCI of a Last Remaining Patent Vessel Is Rare and Risky, UK Data Confirm

September 08, 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

September 03, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.